HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Synergistic effects of interleukin-11 with other growth factors on the expansion of hematopoietic progenitors from normal individuals and chronic myeloid leukemia patients resistant to treatment with cytosine arabinoside or eilatin.

Abstract
Interleukin-11 (IL-11) is a novel cytokine that has been shown to stimulate human hematopoietic progenitors including the CD34+ CD33- DR- early progenitors. IL-11 has little effect on its own but it synergizes with other hematopoietic growth factors. We investigated the recovery of human myeloid progenitors incubated with IL-11 alone or in combination with other cytokines, including stem cell factor (SCF), interleukin-3 (IL-3) and granulocyte macrophage colony-stimulating factor (GM-CSF) following their in vitro treatment with ARA-C (10(-9) M) or Eilatin (10(-7) M). IL-11 in combination with IL-3 and GM-CSF markedly increased CFU-C colony growth pre- and post-ARA-C or Eilatin incubation from CML and normal individual bone marrow (BM) cells. Similarly, IL-11 alone or in combination with other cytokines increased cell recovery following 7-day suspension culture. A decrease in BCR/ABL fusion product was observed (by FISH analysis) after incubation of BM cells from CML patients in liquid culture for 7 days with 10(-9) M ARA-C or 10(-7) M Eilatin in the presence of IL-11 alone or in combination with other cytokines. These results indicate that following cytoreductive therapy IL-11 may enhance to a greater extent the growth of normal myeloid progenitors than the malignant clone and may, therefore, be of clinical importance for CML patients treated with chemotherapeutic agents.
AuthorsM Einat, A Nagler, A Amiel, M D Fejgin, A Rudi, Y Kashman, I Fabian
JournalLeukemia research (Leuk Res) Vol. 20 Issue 9 Pg. 751-9 (Sep 1996) ISSN: 0145-2126 [Print] ENGLAND
PMID8947585 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Interleukin-11
  • Interleukin-3
  • Phenanthrolines
  • Stem Cell Factor
  • Cytarabine
  • eilatine
  • Granulocyte-Macrophage Colony-Stimulating Factor
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • CHO Cells
  • Cricetinae
  • Cytarabine (pharmacology)
  • Dose-Response Relationship, Drug
  • Drug Resistance, Neoplasm
  • Drug Synergism
  • Granulocyte-Macrophage Colony-Stimulating Factor (pharmacology)
  • Hematopoietic Stem Cells (drug effects)
  • Humans
  • Interleukin-11 (pharmacology)
  • Interleukin-3 (pharmacology)
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (blood, drug therapy)
  • Phenanthrolines (pharmacology)
  • Stem Cell Factor (pharmacology)
  • Tumor Stem Cell Assay

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: